Better Care for PFAS Patients Act of 2026
Sens. Shaheen and Collins Introduce Bipartisan Bill to Create Medical Guidelines for PFAS Exposure
Legislative Progress
Key Points
- This bill, introduced by Senators Shaheen and Collins, would require the government to create official medical instructions for doctors on how to treat people exposed to PFAS, often called "forever chemicals."
- The Agency for Toxic Substances and Disease Registry would work with top scientists to study how these chemicals affect the human body and what medical steps doctors should take to help patients.
- The scientists must talk to people living in communities with high PFAS levels to learn about their health experiences and what kind of testing or follow-up care they need.
- New medical guidelines would be released within five years and updated every five years after that to make sure doctors have the most current information as science improves.
- The goal is to help local health departments and doctors across the country better understand and manage the health risks linked to these common chemicals found in water and soil.
Impact Analysis
Personal Impact
Life & Work
Active-duty service members stationed at or near bases where PFAS-containing firefighting foam was used could benefit from improved clinical guidance on screening and treatment. Better medical recommendations mean military healthcare providers would have clearer protocols for managing PFAS-related health risks.
Disabilities
State Impacts
Milestones
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
3 articlesCollins cosponsors measure to regularly update guidance on toxic PFAS
U.S. Sen. Susan Collins (R-ME) on Jan. 8 cosponsored a bipartisan bill to require the Agency for Toxic Substances and Disease Research (ATSDR) to regularly assess and update clinical guidance regarding the health effects from exposure to toxic per- and poly-fluoroalkyl substances (PFAS).
Shaheen, Collins, Dexter, Lawler Introduce Bipartisan, Bicameral Legislation to Help Clinicians Provide Care for Patients Exposed to PFAS
The Better Care for PFAS Patients Act would ensure the Agency for Toxic Substances and Disease Research (ATSDR) regularly assesses and updates clinical guidance regarding the health effects from exposure to PFAS.
Bipartisan Better Care For PFAS Patients Act Introduced In The House And Senate
On January 8, 2026, the Better Care for PFAS Patients Act (H.R. 6977, S. 3598) was introduced. The bill would require ATSDR to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (NASEM) to assess the health effects of PFAS and formulate clinical recommendations.
Source Information
Document Type
Congressional Bill
Official Title
Better Care for PFAS Patients Act of 2026
Data Sources
Sponsor
Cosponsors
(1)Analysis generated by AI. Always verify with official sources.